ATP

ArtNr	HY-B2176-10mM
Hersteller	MedChem Express
CAS-Nr.	56-65-5
Menge	10 mM/1 mL
Quantity options	100 mg 10 mM/1 mL 500 mg
Kategorie	Neuroscience Neuroinflammation Metabolism Diabetes Glucose Homeostasis Inhibitors & Compound Libraries Small Molecules
Typ	Inhibitors
Specific against	other
Purity	99.62
Citations	[1]Swennen EL, et al. Immunoregulatory effects of adenosine 5'-triphosphate on cytokine release from stimulated whole blood. Eur J Immunol. 2005 Mar;35(3):852-8.\|[2]M J L Bours, et al. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther. 2006 Nov;112(2):358-404.\|[3]Shuo Xu, et al. Doxycycline inhibits NAcht Leucine-rich repeat Protein 3 inflammasome activation and interleukin-1β production induced by Porphyromonas gingivalis-lipopolysaccharide and adenosine triphosphate in human gingival fibroblasts. Arch Oral Biol. 2019 Nov;107:104514.\|[4]Yang Xiang, et al. Adenosine-5'-Triphosphate (ATP) Protects Mice against Bacterial Infection by Activation of the NLRP3 Inflammasome. PLoS One. 2013; 8(5): e63759. . 2022 Nov 4.\|ACS Nano. 2023 Nov 21.\|Acta Pharmacol Sin. 2022 Jan 12.\|Aging (Albany NY). 2021 Mar 10;13(6):8588-8598.\|Aging (Albany NY). 2021 Sep 28;13(18):22588-22610.\|Am J Chin Med. 2025 Mar 19:1-22.\|Anal Chim Acta. 18 October 2021, 339180.\|Antioxidants (Basel). 2022, 11(12), 2315.\|Antioxidants (Basel). 2023 Jun 19, 12(6), 1304.\|Appl Microbiol Biotechnol. 2024 Jan 25;108(1):173.\|Arch Oral Biol. 2019 Aug 2;107:104514.\|Biochem Biophys Res Commun. 2024 May 14, 708, 149814.\|Biochem Pharmacol. 2024 Jun 19:116377.\|Biochem Pharmacol. 2025 Feb 12:234:116801.\|Biochemistry. 2023 Nov 10.\|Biochim Biophys Acta Mol Basis Dis. 2023 Sep 23;166895.\|Biochim Biophys Acta Mol Cell Res. 2023 Sep 18;119595.\|Biochim Biophys Acta Mol Cell Res. 2024 Mar 22;1871(4):119712.\|Biomed Pharmacother. 2024 Jul 15:177:117111.\|Biomed Pharmacother. 2024 Jun 21:177:117006.\|Biomed Pharmacother. 2024 Jun 24:177:116952.\|Bioorgan Med Chem. 2021 Jan 1;29:115899.\|bioRxiv. 2024 Apr 21.\|Biosens Bioelectron. 2021 Apr 15;178:113025.\|Cancer Cell Int. 2023 May 9;23(1):87.\|Cancer Lett. 2024 Jul 29:217145.\|Carbohyd Polym. 2020 Jun 1;237:116163.\|Cell Death Differ. 2021 Sep 11.\|Cell Death Dis. 2021 Dec 14;12(12):1159.\|Cell Death Dis. 2022 Oct 8;13(10):860.\|Cell Death Dis. 2020 Feb 18;11(2):132. \|Cell Prolif. 2023 Apr 21;e13442.\|Cell Rep. 2021 Aug 10;36(6):109516.\|Cell Rep. 2024 Jun 27;43(7):114402.\|Cell Rep. 2025 Jan 10;44(1):115203.\|Cell Res. 2025 Feb;35(2):97-116.\|Clin Oral Investig. 2023 Feb 3.\|Crit Care. 2021 Oct 12;25(1):356.\|Cytotechnology. 2025 Apr;77(2):66.\|Eur J Pharmacol. 2021 Dec 29;174729.\|Eur J Pharmacol. 2023 Mar 24;947:175681.\|Front Neurosci. 2022 Jun 7;16:901688.\|Heliyon. 2024 Sep 19;10(19):e38050.\|Immunity. 2024 Mar 12;57(3):495-512.e11.\|Immunotargets Ther. 2024 Dec 14:13:775-788.\|Int Immunopharmacol. 2023 Jan 25;116:109747.\|Int Immunopharmacol. 2024 Nov 2;143(Pt 3):113527.\|Int Immunopharmacol. 2025 Jan 18:148:114057.\|Int J Biol Macromol. 2024 Apr 27;268(Pt 2):131779.\|Int J Dev Neurosci. 2022 Nov 7.\|Int J Mol Sci. 2024 Sep 26;25(19):10366.\|J Agric Food Chem. 2024 Sep 16.\|J Cell Mol Med. 2025 Jan;29(2):e70338.\|J Dent Sci. 2025 Feb 20.\|J Ethnopharmacol. 2023 Nov 8:117388.\|J Ethnopharmacol. 2024 Mar 20:328:118057.\|J Transl Med. 2024 Sep 27;22(1):871.\|J Virol. 2023 Mar 6;e0000323.\|Life Sci. 2021 Feb 9;119192.\|Mater Today Bio. 2025 Apr.\|Mol Cell. 2022 Apr 14:S1097-2765(22)00290-8.\|Mol Cell. 2023 May 19;S1097-2765(23)00324-6.\|Mol Immunol. 2024 May:169:86-98.\|Nutrients. 2021, 13(12), 4462.\|Oral Dis. 2020 Sep 28. \|Phytomedicine. 2023 Nov 8, 155193.\|Phytomedicine.2023 Sep:118:154971.\|Proc Natl Acad Sci U S A. 2025 Feb 25;122(8):e2424906122.\|Protein Cell. 2021 Oct 22;1-21.\|Reprod Biomed Online. 2024 Jun 11.\|Res Sq. 2024 Sep 22.\|Research Square Preprint. 2021 Jul.\|Research Square Preprint. 2022 Feb.\|Research Square Preprint. 2022 May.\|Research Square Preprint. 2023 Sep 8.\|Research Square Preprint. 2024 Apr 9.\|Respir Res. 2024 Jul 30;25(1):291.\|SSRN. 2023 May 12.\|SSRN. 2024 Nov 19.\|SSRN. 6 Dec 2022.\|Transl Res. 2022.\|Vet Sci. 2024 Dec 12;11(12):643.\|Cell Death Dis. 2020 Jan 30;11(1):78.\|Cell Death Dis. 2023 Mar 1;14(3):174.\|Cell Rep. 2024 Sep 28;43(10):114794.\|Research Square Preprint. 2020 Dec.\|Int Immunopharmacol. 2023 Feb 21;117:109917.
Smiles	O=P(O)(O)OP(OP(OC[C@H]1O[C@@H](N2C3=NC=NC(N)=C3N=C2)[C@H](O)[C@@H]1O)(O)=O)(O)=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Adenosine 5'-triphosphate
Versandbedingung	Gekühlt
Lieferbar
Manufacturer - Type	Natural Products
Manufacturer - Applications	COVID-19-immunoregulation
Manufacturer - Targets	Endogenous Metabolite
Shipping Temperature	Blue Ice
Storage Conditions	-20°C (Powder, sealed storage, away from moisture)
Molecular Weight	507.18
Product Description	ATP (Adenosine 5'-triphosphate) is a central component of energy storage and metabolism in vivo. ATP provides the metabolic energy to drive metabolic pumps and serves as a coenzyme in cells. ATP is an important endogenous signaling molecule in immunity and inflammation[1][2].
Manufacturer - Research Area	Metabolic Disease; Inflammation/Immunology
Solubility	H2O: ≥ 100 mg/mL
Manufacturer - Pathway	Metabolic Enzyme/Protease
Isoform	Human Endogenous Metabolite
Clinical information	Launched

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkt-Datenblatt anfordern

HY-B2176-10mM-safety-datasheet.pdf